 | | A1IYE | | Name: | 2-[3-[(2~{R})-3-(4-bromophenyl)-4-oxidanyl-5-oxidanylidene-2~{H}-furan-2-yl]phenoxy]ethanoic acid | | Formula: | C18 H13 Br O6 | | SMILES: | OC(=O)COc1cccc(c1)[CH]2OC(=O)C(=C2c3ccc(Br)cc3)O | | InChi: | InChI=1S/C18H13BrO6/c19-12-6-4-10(5-7-12)15-16(22)18(23)25-17(15)11-2-1-3-13(8-11)24-9-14(20)21/h1-8,17,22H,9H2,(H,20,21)/t17-/m1/s1 | | Definition date: | 2025-01-10 | | Last modified: | 2025-05-09 | | Release date: | 2025-05-14 | | Identifier: | 2-[3-[(2~{R})-3-(4-bromophenyl)-4-oxidanyl-5-oxidanylidene-2~{H}-furan-2-yl]phenoxy]ethanoic acid |
|
 | | A1L1U | | Name: | Nocardicin G | | Formula: | C19 H19 N3 O6 | | SMILES: | N[CH](C(=O)N[CH]1CN([CH](C(O)=O)c2ccc(O)cc2)C1=O)c3ccc(O)cc3 | | InChi: | InChI=1S/C19H19N3O6/c20-15(10-1-5-12(23)6-2-10)17(25)21-14-9-22(18(14)26)16(19(27)28)11-3-7-13(24)8-4-11/h1-8,14-16,23-24H,9,20H2,(H,21,25)(H,27,28)/t14-,15-,16-/m0/s1 | | Synonyms: | (2~{R})-2-[(3~{S})-3-[[(2~{R})-2-azanyl-2-(4-hydroxyphenyl)ethanoyl]amino]-2-oxidanylidene-azetidin-1-yl]-2-(4-hydroxyphenyl)ethanoic acid | | Definition date: | 2024-05-14 | | Last modified: | 2025-05-09 | | Release date: | 2025-05-14 | | Identifier: | (2~{R})-2-[(3~{S})-3-[[(2~{R})-2-azanyl-2-(4-hydroxyphenyl)ethanoyl]amino]-2-oxidanylidene-azetidin-1-yl]-2-(4-hydroxyphenyl)ethanoic acid |
|
 | | A1L7Q | | Name: | 1-(2-azanylideneethyl)-6-(1,3-dihydroisoindol-2-yl)-3-(5-methylpyridin-3-yl)-5-[[3,4,5-tris(fluoranyl)phenyl]methyl]pyrimidine-2,4-dione | | Formula: | C27 H22 F3 N5 O2 | | SMILES: | Cc1cncc(c1)N2C(=O)N(CC=N)C(=C(Cc3cc(F)c(F)c(F)c3)C2=O)N4Cc5ccccc5C4 | | InChi: | InChI=1S/C27H22F3N5O2/c1-16-8-20(13-32-12-16)35-26(36)21(9-17-10-22(28)24(30)23(29)11-17)25(34(7-6-31)27(35)37)33-14-18-4-2-3-5-19(18)15-33/h2-6,8,10-13,31H,7,9,14-15H2,1H3/b31-6- | | Definition date: | 2025-02-19 | | Last modified: | 2025-05-09 | | Release date: | 2025-05-14 | | Identifier: | 1-(2-azanylideneethyl)-6-(1,3-dihydroisoindol-2-yl)-3-(5-methylpyridin-3-yl)-5-[[3,4,5-tris(fluoranyl)phenyl]methyl]pyrimidine-2,4-dione |
|
 | | A1L7R | | Name: | 1-(2-azanylideneethyl)-6-[6,6-bis(fluoranyl)-2-azaspiro[3.3]heptan-2-yl]-5-(3-chloranyl-4-fluoranyl-phenyl)-3-(5-chloranylpyridin-3-yl)pyrimidine-2,4-dione | | Formula: | C23 H18 Cl2 F3 N5 O2 | | SMILES: | Fc1ccc(cc1Cl)C2=C(N3CC4(C3)CC(F)(F)C4)N(CC=N)C(=O)N(C2=O)c5cncc(Cl)c5 | | InChi: | InChI=1S/C23H18Cl2F3N5O2/c24-14-6-15(8-30-7-14)33-20(34)18(13-1-2-17(26)16(25)5-13)19(32(4-3-29)21(33)35)31-11-22(12-31)9-23(27,28)10-22/h1-3,5-8,29H,4,9-12H2 | | Definition date: | 2025-02-19 | | Last modified: | 2025-05-09 | | Release date: | 2025-05-14 | | Identifier: | 1-(2-azanylideneethyl)-6-[6,6-bis(fluoranyl)-2-azaspiro[3.3]heptan-2-yl]-5-(3-chloranyl-4-fluoranyl-phenyl)-3-(5-chloranylpyridin-3-yl)pyrimidine-2,4-dione |
|
 | | A1L9C | | Name: | ~{N}-[4-[4-[3,4,5-tris(oxidanyl)phenyl]carbonylpiperazin-1-yl]sulfonylphenyl]ethanamide | | Formula: | C19 H21 N3 O7 S | | SMILES: | CC(=O)Nc1ccc(cc1)[S](=O)(=O)N2CCN(CC2)C(=O)c3cc(O)c(O)c(O)c3 | | InChi: | InChI=1S/C19H21N3O7S/c1-12(23)20-14-2-4-15(5-3-14)30(28,29)22-8-6-21(7-9-22)19(27)13-10-16(24)18(26)17(25)11-13/h2-5,10-11,24-26H,6-9H2,1H3,(H,20,23) | | Definition date: | 2025-04-28 | | Last modified: | 2025-05-09 | | Release date: | 2025-05-14 | | Identifier: | ~{N}-[4-[4-[3,4,5-tris(oxidanyl)phenyl]carbonylpiperazin-1-yl]sulfonylphenyl]ethanamide |
|
 | | M12 | | Name: | 10-METHYLUNDECANOIC ACID | | Formula: | C12 H24 O2 | | SMILES: | O=C(O)CCCCCCCCC(C)C | | InChi: | InChI=1S/C12H24O2/c1-11(2)9-7-5-3-4-6-8-10-12(13)14/h11H,3-10H2,1-2H3,(H,13,14) | | Definition date: | 2010-07-29 | | Last modified: | 2025-05-08 | | Identifier: | 10-methylundecanoic acid |
|
 | | CGL | | Name: | CYSTINE-GLUTATHIONE | | Formula: | C13 H22 N4 O8 S2 | | SMILES: | O=C(NC(CSSCC(N)C(=O)O)C(=O)NCC(=O)O)CCC(N)C(=O)O | | InChi: | InChI=1S/C13H22N4O8S2/c14-6(12(22)23)1-2-9(18)17-8(11(21)16-3-10(19)20)5-27-26-4-7(15)13(24)25/h6-8H,1-5,14-15H2,(H,16,21)(H,17,18)(H,19,20)(H,22,23)(H,24,25)/t6-,7-,8-/m0/s1 | | Synonyms: | (2S)-2-amino-5-({(2R)-3-{[(2R)-2-amino-2-carboxyethyl]disulfanyl}-1-[(carboxymethyl)amino]-1-oxopropan-2-yl}amino)-5-oxopentanoic acid (non-preferred name) | | Definition date: | 1999-07-08 | | Last modified: | 2025-05-05 | | Identifier: | (2S)-2-amino-5-({(2R)-3-{[(2R)-2-amino-2-carboxyethyl]disulfanyl}-1-[(carboxymethyl)amino]-1-oxopropan-2-yl}amino)-5-oxopentanoic acid (non-preferred name) |
|
 | | WB3 | | Name: | (2E)-3-[4-({2-[(1-{[4-(methanesulfonyl)phenyl]methyl}piperidin-4-yl)amino]pyrido[2,3-d]pyrimidin-4-yl}oxy)-3,5-dimethylphenyl]prop-2-enenitrile | | Formula: | C31 H32 N6 O3 S | | SMILES: | Cc1cc(C=CC#N)cc(C)c1Oc1nc(nc2ncccc21)NC1CCN(Cc2ccc(cc2)S(C)(=O)=O)CC1 | | InChi: | InChI=1S/C31H32N6O3S/c1-21-18-24(6-4-14-32)19-22(2)28(21)40-30-27-7-5-15-33-29(27)35-31(36-30)34-25-12-16-37(17-13-25)20-23-8-10-26(11-9-23)41(3,38)39/h4-11,15,18-19,25H,12-13,16-17,20H2,1-3H3,(H,33,34,35,36)/b6-4+ | | Definition date: | 2022-05-27 | | Last modified: | 2025-05-02 | | Release date: | 2025-05-07 | | Identifier: | (2E)-3-[4-({2-[(1-{[4-(methanesulfonyl)phenyl]methyl}piperidin-4-yl)amino]pyrido[2,3-d]pyrimidin-4-yl}oxy)-3,5-dimethylphenyl]prop-2-enenitrile |
|
 | | YC6 | | Name: | 1-(2-deoxy-alpha-D-erythro-pentofuranosyl)-5-methylpyrimidine-2,4(1H,3H)-dione | | Formula: | C10 H12 N2 O6 | | SMILES: | O=CC1=CN(C(=O)NC1=O)C1CC(O)C(CO)O1 | | InChi: | InChI=1S/C10H12N2O6/c13-3-5-2-12(10(17)11-9(5)16)8-1-6(15)7(4-14)18-8/h2-3,6-8,14-15H,1,4H2,(H,11,16,17)/t6-,7+,8-/m0/s1 | | Definition date: | 2023-11-30 | | Last modified: | 2025-05-02 | | Release date: | 2025-05-07 | | Identifier: | 1-(2-deoxy-alpha-D-erythro-pentofuranosyl)-2,4-dioxo-1,2,3,4-tetrahydropyrimidine-5-carbaldehyde |
|
 | | YGF | | Name: | (3aS,4R,7R,10aS)-2,6-diamino-4-(hydroxymethyl)-3a,4,8,9-tetrahydro-1H,10H-pyrrolo[1,2-c]purine-10,10-diol | | Formula: | C9 H16 N6 O3 | | SMILES: | NC1=NC(CO)C2N=C(N)NC22N1CCC2(O)O | | InChi: | InChI=1S/C9H16N6O3/c10-6-13-5-4(3-16)12-7(11)15-2-1-8(17,18)9(5,15)14-6/h4-5,16-18H,1-3H2,(H2,11,12)(H3,10,13,14)/t4-,5-,9-/m0/s1 | | Definition date: | 2023-12-04 | | Last modified: | 2025-05-02 | | Release date: | 2025-05-07 | | Identifier: | (3aS,4R,7R,10aS)-2,6-diamino-4-(hydroxymethyl)-3a,4,8,9-tetrahydro-1H,10H-pyrrolo[1,2-c]purine-10,10-diol |
|
 | | YGU | | Name: | (3aS,4R,7R,9R,10aS)-2,6-diamino-10,10-dihydroxy-4-(hydroxymethyl)-3a,4,9,10-tetrahydro-1H,8H-pyrrolo[1,2-c]purin-9-yl hydrogen sulfate | | Formula: | C9 H16 N6 O7 S | | SMILES: | O=S(=O)(O)OC1CN2C(N)=NC(CO)C3N=C(N)NC32C1(O)O | | InChi: | InChI=1S/C9H16N6O7S/c10-6-13-5-3(2-16)12-7(11)15-1-4(22-23(19,20)21)9(17,18)8(5,15)14-6/h3-5,16-18H,1-2H2,(H2,11,12)(H3,10,13,14)(H,19,20,21)/t3-,4+,5-,8-/m0/s1 | | Definition date: | 2023-12-04 | | Last modified: | 2025-05-02 | | Release date: | 2025-05-07 | | Identifier: | (3aS,4R,7R,9R,10aS)-2,6-diamino-10,10-dihydroxy-4-(hydroxymethyl)-3a,4,9,10-tetrahydro-1H,8H-pyrrolo[1,2-c]purin-9-yl hydrogen sulfate |
|
 | | YGZ | | Name: | ({[(3aS,4R,7S,10aS)-2,6-diamino-10,10-dihydroxy-3a,4,9,10-tetrahydro-1H,8H-pyrrolo[1,2-c]purin-4-yl]methoxy}carbonyl)sulfamic acid | | Formula: | C10 H17 N7 O7 S | | SMILES: | O=S(=O)(O)NC(=O)OCC1N=C(N)N2CCC(O)(O)C32NC(N)=NC13 | | InChi: | InChI=1S/C10H17N7O7S/c11-6-14-5-4(3-24-8(18)16-25(21,22)23)13-7(12)17-2-1-9(19,20)10(5,17)15-6/h4-5,19-20H,1-3H2,(H2,12,13)(H,16,18)(H3,11,14,15)(H,21,22,23)/t4-,5-,10-/m0/s1 | | Definition date: | 2023-12-04 | | Last modified: | 2025-05-02 | | Release date: | 2025-05-07 | | Identifier: | ({[(3aS,4R,7S,10aS)-2,6-diamino-10,10-dihydroxy-3a,4,9,10-tetrahydro-1H,8H-pyrrolo[1,2-c]purin-4-yl]methoxy}carbonyl)sulfamic acid |
|
 | | YH9 | | Name: | ({[(3aS,4R,7R,9R,10aS)-2,6-diamino-10,10-dihydroxy-9-(sulfooxy)-3a,4,9,10-tetrahydro-1H,8H-pyrrolo[1,2-c]purin-4-yl]methoxy}carbonyl)sulfamic acid | | Formula: | C10 H17 N7 O11 S2 | | SMILES: | O=S(=O)(O)NC(=O)OCC1N=C(N)N2CC(OS(=O)(=O)O)C(O)(O)C32NC(N)=NC13 | | InChi: | InChI=1S/C10H17N7O11S2/c11-6-14-5-3(2-27-8(18)16-29(21,22)23)13-7(12)17-1-4(28-30(24,25)26)10(19,20)9(5,17)15-6/h3-5,19-20H,1-2H2,(H2,12,13)(H,16,18)(H3,11,14,15)(H,21,22,23)(H,24,25,26)/t3-,4+,5-,9-/m0/s1 | | Definition date: | 2023-12-04 | | Last modified: | 2025-05-02 | | Release date: | 2025-05-07 | | Identifier: | ({[(3aS,4R,7R,9R,10aS)-2,6-diamino-10,10-dihydroxy-9-(sulfooxy)-3a,4,9,10-tetrahydro-1H,8H-pyrrolo[1,2-c]purin-4-yl]methoxy}carbonyl)sulfamic acid |
|
 | | A1ATW | | Name: | N-(1-{3,5-difluoro-4-[(4-{[fluorodi(hydroxy)-lambda~4~-sulfanyl]oxy}phenoxy)methyl]phenyl}-1H-1,2,4-triazol-3-yl)methanesulfonamide | | Formula: | C16 H15 F3 N4 O6 S2 | | SMILES: | FS(O)(O)Oc1ccc(cc1)OCc1c(F)cc(cc1F)n1cnc(n1)NS(C)(=O)=O | | InChi: | InChI=1S/C16H15F3N4O6S2/c1-30(24,25)22-16-20-9-23(21-16)10-6-14(17)13(15(18)7-10)8-28-11-2-4-12(5-3-11)29-31(19,26)27/h2-7,9,26-27H,8H2,1H3,(H,21,22) | | Definition date: | 2024-05-31 | | Last modified: | 2025-05-02 | | Release date: | 2025-05-07 | | Identifier: | N-(1-{3,5-difluoro-4-[(4-{[fluorodi(hydroxy)-lambda~4~-sulfanyl]oxy}phenoxy)methyl]phenyl}-1H-1,2,4-triazol-3-yl)methanesulfonamide |
|
 | | A1B6Y | | Name: | 2-amino-3-methyl-N-(2-methylpropyl)-N-{[5-(trifluoromethyl)pyridin-2-yl]methyl}quinoline-6-carboxamide | | Formula: | C22 H23 F3 N4 O | | SMILES: | Cc1cc2cc(ccc2nc1N)C(=O)N(CC(C)C)Cc1ccc(cn1)C(F)(F)F | | InChi: | InChI=1S/C22H23F3N4O/c1-13(2)11-29(12-18-6-5-17(10-27-18)22(23,24)25)21(30)15-4-7-19-16(9-15)8-14(3)20(26)28-19/h4-10,13H,11-12H2,1-3H3,(H2,26,28) | | Definition date: | 2025-03-25 | | Last modified: | 2025-05-02 | | Release date: | 2025-05-07 | | Identifier: | 2-amino-3-methyl-N-(2-methylpropyl)-N-{[5-(trifluoromethyl)pyridin-2-yl]methyl}quinoline-6-carboxamide |
|
 | | A1BKY | | Name: | N-[3-bromo-5-(methanesulfonamido)phenyl]-4-phenylthiophene-2-carboxamide | | Formula: | C18 H15 Br N2 O3 S2 | | SMILES: | CS(=O)(=O)Nc1cc(cc(Br)c1)NC(=O)c1cc(cs1)c1ccccc1 | | InChi: | InChI=1S/C18H15BrN2O3S2/c1-26(23,24)21-16-9-14(19)8-15(10-16)20-18(22)17-7-13(11-25-17)12-5-3-2-4-6-12/h2-11,21H,1H3,(H,20,22) | | Definition date: | 2024-12-11 | | Last modified: | 2025-05-02 | | Release date: | 2025-05-07 | | Identifier: | N-[3-bromo-5-(methanesulfonamido)phenyl]-4-phenylthiophene-2-carboxamide |
|
 | | A1BKZ | | Name: | N-[3-(methanesulfonamido)phenyl]-4-phenylthiophene-2-carboxamide | | Formula: | C18 H16 N2 O3 S2 | | SMILES: | CS(=O)(=O)Nc1cccc(c1)NC(=O)c1cc(cs1)c1ccccc1 | | InChi: | InChI=1S/C18H16N2O3S2/c1-25(22,23)20-16-9-5-8-15(11-16)19-18(21)17-10-14(12-24-17)13-6-3-2-4-7-13/h2-12,20H,1H3,(H,19,21) | | Definition date: | 2024-12-11 | | Last modified: | 2025-05-02 | | Release date: | 2025-05-07 | | Identifier: | N-[3-(methanesulfonamido)phenyl]-4-phenylthiophene-2-carboxamide |
|
 | | A1EJO | | Name: | 3-[2-[(2~{S})-butan-2-yl]-1,3-benzothiazol-5-yl]-1-~{tert}-butyl-pyrazolo[3,4-d]pyrimidin-4-amine | | Formula: | C20 H24 N6 S | | SMILES: | CC[CH](C)c1sc2ccc(cc2n1)c3nn(c4ncnc(N)c34)C(C)(C)C | | InChi: | InChI=1S/C20H24N6S/c1-6-11(2)19-24-13-9-12(7-8-14(13)27-19)16-15-17(21)22-10-23-18(15)26(25-16)20(3,4)5/h7-11H,6H2,1-5H3,(H2,21,22,23)/t11-/m0/s1 | | Definition date: | 2025-01-16 | | Last modified: | 2025-05-02 | | Release date: | 2025-05-07 | | Identifier: | 3-[2-[(2~{S})-butan-2-yl]-1,3-benzothiazol-5-yl]-1-~{tert}-butyl-pyrazolo[3,4-d]pyrimidin-4-amine |
|
 | | A1EKY | | Name: | 3-(4-phenoxyphenyl)-1-piperidin-4-yl-pyrazolo[3,4-d]pyrimidin-4-amine | | Formula: | C22 H22 N6 O | | SMILES: | Nc1ncnc2n(nc(c3ccc(Oc4ccccc4)cc3)c12)C5CCNCC5 | | InChi: | InChI=1S/C22H22N6O/c23-21-19-20(15-6-8-18(9-7-15)29-17-4-2-1-3-5-17)27-28(22(19)26-14-25-21)16-10-12-24-13-11-16/h1-9,14,16,24H,10-13H2,(H2,23,25,26) | | Synonyms: | N-piperidine Ibrutinib | | Definition date: | 2025-01-29 | | Last modified: | 2025-05-02 | | Release date: | 2025-05-07 | | Identifier: | 3-(4-phenoxyphenyl)-1-piperidin-4-yl-pyrazolo[3,4-d]pyrimidin-4-amine |
|
 | | A1EPQ | | Name: | 10',11'-difluoro-12'-methoxyvinblastine | | Formula: | C47 H58 F2 N4 O10 | | SMILES: | CC[C]1(O)C[CH]2C[N](CCc3c([nH]c4cc(F)c(F)c(OC)c34)[C](C2)(C(=O)OC)c5cc6c(cc5OC)N(C)[CH]7[C](O)([CH](OC(C)=O)[C]8(CC)C=CCN9CC[C]67[CH]89)C(=O)OC)C1 | | InChi: | InChI=1S/C47H58F2N4O10/c1-9-43(57)21-26-22-46(41(55)61-7,37-27(12-16-52(23-26)24-43)34-31(50-37)19-30(48)35(49)36(34)60-6)29-18-28-32(20-33(29)59-5)51(4)39-45(28)14-17-53-15-11-13-44(10-2,38(45)53)40(63-25(3)54)47(39,58)42(56)62-8/h11,13,18-20,26,38-40,50,57-58H,9-10,12,14-17,21-24H2,1-8H3/t26-,38-,39+,40+,43-,44+,45+,46-,47-/m0/s1 | | Definition date: | 2025-04-24 | | Last modified: | 2025-05-02 | | Release date: | 2025-05-07 |
|
 | | A1EPR | | Name: | 10'-fluorovinblastine | | Formula: | C46 H57 F N4 O9 | | SMILES: | CC[C]1(O)C[CH]2C[N](CCc3c([nH]c4cc(F)ccc34)[C](C2)(C(=O)OC)c5cc6c(cc5OC)N(C)[CH]7[C](O)([CH](OC(C)=O)[C]8(CC)C=CCN9CC[C]67[CH]89)C(=O)OC)C1 | | InChi: | InChI=1S/C46H57FN4O9/c1-8-42(55)22-27-23-45(40(53)58-6,36-30(13-17-50(24-27)25-42)29-12-11-28(47)19-33(29)48-36)32-20-31-34(21-35(32)57-5)49(4)38-44(31)15-18-51-16-10-14-43(9-2,37(44)51)39(60-26(3)52)46(38,56)41(54)59-7/h10-12,14,19-21,27,37-39,48,55-56H,8-9,13,15-18,22-25H2,1-7H3/t27-,37-,38+,39+,42-,43+,44+,45-,46-/m0/s1 | | Definition date: | 2025-04-24 | | Last modified: | 2025-05-02 | | Release date: | 2025-05-07 |
|
 | | A1EPS | | Name: | 10'-bromovinblastine | | Formula: | C46 H57 Br N4 O9 | | SMILES: | CC[C]1(O)C[CH]2C[N](CCc3c([nH]c4cc(Br)ccc34)[C](C2)(C(=O)OC)c5cc6c(cc5OC)N(C)[CH]7[C](O)([CH](OC(C)=O)[C]8(CC)C=CCN9CC[C]67[CH]89)C(=O)OC)C1 | | InChi: | InChI=1S/C46H57BrN4O9/c1-8-42(55)22-27-23-45(40(53)58-6,36-30(13-17-50(24-27)25-42)29-12-11-28(47)19-33(29)48-36)32-20-31-34(21-35(32)57-5)49(4)38-44(31)15-18-51-16-10-14-43(9-2,37(44)51)39(60-26(3)52)46(38,56)41(54)59-7/h10-12,14,19-21,27,37-39,48,55-56H,8-9,13,15-18,22-25H2,1-7H3/t27-,37-,38+,39+,42+,43+,44+,45-,46-/m0/s1 | | Definition date: | 2025-04-24 | | Last modified: | 2025-05-02 | | Release date: | 2025-05-07 |
|
 | | A1EPT | | Name: | 10'-methoxyvinblastine | | Formula: | C47 H60 N4 O10 | | SMILES: | CC[C]1(O)C[CH]2C[N](CCc3c([nH]c4cc(OC)ccc34)[C](C2)(C(=O)OC)c5cc6c(cc5OC)N(C)[CH]7[C](O)([CH](OC(C)=O)[C]8(CC)C=CCN9CC[C]67[CH]89)C(=O)OC)C1 | | InChi: | InChI=1S/C47H60N4O10/c1-9-43(55)23-28-24-46(41(53)59-7,37-31(14-18-50(25-28)26-43)30-13-12-29(57-5)20-34(30)48-37)33-21-32-35(22-36(33)58-6)49(4)39-45(32)16-19-51-17-11-15-44(10-2,38(45)51)40(61-27(3)52)47(39,56)42(54)60-8/h11-13,15,20-22,28,38-40,48,55-56H,9-10,14,16-19,23-26H2,1-8H3/t28-,38-,39+,40+,43-,44+,45+,46-,47-/m0/s1 | | Definition date: | 2025-04-24 | | Last modified: | 2025-05-02 | | Release date: | 2025-05-07 |
|
 | | A1BYY | | Name: | 4-({5-amino-1-[6-(2-cyanoethyl)naphthalene-1-sulfonyl]-1H-1,2,4-triazol-3-yl}amino)-2-chlorobenzonitrile | | Formula: | C22 H16 Cl N7 O2 S | | SMILES: | O=S(=O)(c1cccc2cc(CCC#N)ccc21)n1nc(Nc2ccc(C#N)c(Cl)c2)nc1N | | InChi: | InChI=1S/C22H16ClN7O2S/c23-19-12-17(8-7-16(19)13-25)27-22-28-21(26)30(29-22)33(31,32)20-5-1-4-15-11-14(3-2-10-24)6-9-18(15)20/h1,4-9,11-12H,2-3H2,(H3,26,27,28,29) | | Definition date: | 2025-03-04 | | Last modified: | 2025-05-02 | | Release date: | 2025-05-07 | | Identifier: | 4-({5-amino-1-[6-(2-cyanoethyl)naphthalene-1-sulfonyl]-1H-1,2,4-triazol-3-yl}amino)-2-chlorobenzonitrile |
|
 | | A1D9F | | Name: | ~{N}-[(1-fluoranylcyclohexyl)methyl]-~{N}-methyl-4-(2-methylsulfanylphenyl)-2-methylsulfonyl-benzamide | | Formula: | C23 H28 F N O3 S2 | | SMILES: | CSc1ccccc1c2ccc(C(=O)N(C)CC3(F)CCCCC3)c(c2)[S](C)(=O)=O | | InChi: | InChI=1S/C23H28FNO3S2/c1-25(16-23(24)13-7-4-8-14-23)22(26)19-12-11-17(15-21(19)30(3,27)28)18-9-5-6-10-20(18)29-2/h5-6,9-12,15H,4,7-8,13-14,16H2,1-3H3 | | Definition date: | 2024-06-20 | | Last modified: | 2025-05-02 | | Release date: | 2025-05-07 | | Identifier: | ~{N}-[(1-fluoranylcyclohexyl)methyl]-~{N}-methyl-4-(2-methylsulfanylphenyl)-2-methylsulfonyl-benzamide |
|